132 related articles for article (PubMed ID: 34618714)
1. NONPARANEOPLASTIC AUTOIMMUNE RETINOPATHY VERSUS PERICENTRAL RETINAL DEGENERATION PHENOTYPE: WHICH CAME FIRST? A CASE REPORT.
Garcia CM; Maleki A; Look-Why S; Manhapra A; Durrani K; Foster CS
Retin Cases Brief Rep; 2023 Jul; 17(4):384-388. PubMed ID: 34618714
[TBL] [Abstract][Full Text] [Related]
2. Presumed autoimmune retinopathy following chickenpox; a case report.
Prime Z; Sims J; Danesh-Meyer H
Int Ophthalmol; 2018 Oct; 38(5):2187-2190. PubMed ID: 28825165
[TBL] [Abstract][Full Text] [Related]
3. Non-Paraneoplastic Autoimmune Retinopathy: The First Case Report in Korea.
Choi EY; Kim M; Adamus G; Koh HJ; Lee SC
Yonsei Med J; 2016 Mar; 57(2):527-31. PubMed ID: 26847311
[TBL] [Abstract][Full Text] [Related]
4. Nonparaneoplastic autoimmune retinopathy presenting with peripheral retinal vasoocclusion: case report.
Lin CJ; Chen SN; Hwang JF; Tseng CC; Li KH
Retin Cases Brief Rep; 2013; 7(1):41-5. PubMed ID: 25390519
[TBL] [Abstract][Full Text] [Related]
5. A MIDDLE-AGED PATIENT WITH BILATERAL VISION LOSS AND NYCTALOPIA.
Romero-Morales VA; Peiris TJ; Somisetty S; Santina A; Lu A; Sarraf D
Retin Cases Brief Rep; 2023 Jun; 17(4S):S19-S22. PubMed ID: 36007183
[TBL] [Abstract][Full Text] [Related]
6. Remission of nonparaneoplastic autoimmune retinopathy after minimal steroid treatment.
Bursztyn LL; Belrose JC; Coupland SG; Fraser JA; Proulx AA
Retin Cases Brief Rep; 2015; 9(2):173-6. PubMed ID: 25764315
[TBL] [Abstract][Full Text] [Related]
7. Rituximab treatment for nonparaneoplastic autoimmune retinopathy.
Fox A; Jeffrey B; Hasni S; Nussenblatt R; Sen HN
Can J Ophthalmol; 2015 Dec; 50(6):e101-4. PubMed ID: 26651312
[No Abstract] [Full Text] [Related]
8. Combination Treatment with Rituximab and Bortezomib in a Patient with Non-Paraneoplastic Autoimmune Retinopathy.
Benson MD; Plemel DJA; Yacyshyn E; Sandhu I; MacDonald IM; Baker CF
Ocul Immunol Inflamm; 2020 Aug; 28(6):958-965. PubMed ID: 31418623
[TBL] [Abstract][Full Text] [Related]
9. Retinal degeneration in autoimmune polyglandular syndrome type 1: a case series.
Bourgault S; Baril C; Vincent A; Héon E; Ali A; MacDonald I; Lueder GT; Colleaux KM; Laliberté I
Br J Ophthalmol; 2015 Nov; 99(11):1536-42. PubMed ID: 25926518
[TBL] [Abstract][Full Text] [Related]
10. A case report of acute zonal occult outer retinopathy.
Kaye R; De Salvo G
Eur J Ophthalmol; 2019 Jul; 29(1_suppl):27-31. PubMed ID: 31282209
[TBL] [Abstract][Full Text] [Related]
11. Seroreactivity against retinal proteins in a case of POC1B gene associated cone dystrophy with normal funduscopic appearance: a systematic approach to diagnosis.
Yanık Ö; Batıoğlu F; Sahin Y; Demirel S; Özmert E
Ophthalmic Genet; 2023 Aug; 44(4):389-395. PubMed ID: 36094084
[TBL] [Abstract][Full Text] [Related]
12. Consensus on the Diagnosis and Management of Nonparaneoplastic Autoimmune Retinopathy Using a Modified Delphi Approach.
Fox AR; Gordon LK; Heckenlively JR; Davis JL; Goldstein DA; Lowder CY; Nussenblatt RB; Butler NJ; Dalal M; Jayasundera T; Smith WM; Lee RW; Adamus G; Chan CC; Hooks JJ; Morgans CW; Detrick B; Sen HN
Am J Ophthalmol; 2016 Aug; 168():183-190. PubMed ID: 27210277
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune retinopathy associated with monoclonal gammopathy of undetermined significance: a case report.
Eton EA; Abrams G; Khan NW; Fahim AT
BMC Ophthalmol; 2020 Apr; 20(1):153. PubMed ID: 32299429
[TBL] [Abstract][Full Text] [Related]
14. Acute progressive paravascular placoid neuroretinopathy with negative-type electroretinography in paraneoplastic retinopathy.
Chen FK; Chew AL; Zhang D; Chen SC; Chelva E; Chandrasekera E; Koay EMH; Forrester J; McLenachan S
Doc Ophthalmol; 2017 Jun; 134(3):227-235. PubMed ID: 28382556
[TBL] [Abstract][Full Text] [Related]
15. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies.
Weleber RG; Watzke RC; Shults WT; Trzupek KM; Heckenlively JR; Egan RA; Adamus G
Am J Ophthalmol; 2005 May; 139(5):780-94. PubMed ID: 15860281
[TBL] [Abstract][Full Text] [Related]
16. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Karatsai E; Robson AG; Taylor SRJ
JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
[TBL] [Abstract][Full Text] [Related]
17. RECONSTITUTION OF THE ELLIPSOID ZONE WITH TOCILIZUMAB IN AUTOIMMUNE RETINOPATHY.
Finn AP; Keenan RT; Jaffe GJ
Retin Cases Brief Rep; 2020; 14(4):297-300. PubMed ID: 29952844
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial Retinopathy.
Birtel J; von Landenberg C; Gliem M; Gliem C; Reimann J; Kunz WS; Herrmann P; Betz C; Caswell R; Nesbitt V; Kornblum C; Charbel Issa P
Ophthalmol Retina; 2022 Jan; 6(1):65-79. PubMed ID: 34257060
[TBL] [Abstract][Full Text] [Related]
19. AUTOIMMUNE RETINOPATHY IN A PATIENT WITH A MISSENSE MUTATION IN PITPNM3.
Bakhoum MF; Sengillo JD; Cui X; Tsang SH
Retin Cases Brief Rep; 2018 Fall; 12 Suppl 1(Suppl 1):S72-S75. PubMed ID: 29176531
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Associated Retinopathy and Treatment with Intravenous Immunoglobulin Therapy. A Seldom Used Approach?
Ramos-Ruperto L; Busca-Arenzana C; Boto-de Los Bueis A; Schlincker A; Arnalich-Fernández F; Robles-Marhuenda Á
Ocul Immunol Inflamm; 2021 Feb; 29(2):399-402. PubMed ID: 31710513
[No Abstract] [Full Text] [Related]
[Next] [New Search]
